Contractor
SRI INTERNATIONAL
- UEI
- SRG2J1WS9X63
- Parent UEI
- SRG2J1WS9X63
- Resolved by
- uei
- Confidence
- 1.000
Active from Oct 10, 2003 to Oct 13, 2026.
Sign in to watchWhat they win
Benchmark categories this contractor appears in, by award count.
| Category | Awards | Obligated |
|---|---|---|
| Engineering Services | 2 | $485,401 |
| Program Management Support | 1 | $0 |
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75N93020D00011 RADIATION/ NUCLEAR MEDICAL COUNTERMEASURE PRODUCT DEVELOPMENT SUPPORT | Department of Health and Human Services | — | Jun 30, 2020 | — |
| HHSO100201600007C IGF::OT::IGF POINT-OF-CARE DIAGNOSTIC ASSAY SYSTEM FOR ANTHRAX | Department of Health and Human Services | CA | May 6, 2016 | $19,405,184 |
| 75N94026F00002 NICHD: R&D SERVICES: IN VIVO EFFICACY, VALIDATION AND PRECLINICAL DEVELOPMENT FOR FERTILITY REGULATION, MULTIPURPOSE PREVENTION TECHNOLOGY AND REPRODUCTIVE HEALTH RELATED PRODUCTS (REPRO TASK ORDER): NON-SEVERABLE | Department of Health and Human Services | CA | Sep 26, 2026 | $1,719,885 |
| 75N94026F00001 NICHD: R&D SERVICES: BIOLOGICAL TESTING FACILITY: SEVERABLE | Department of Health and Human Services | CA | Sep 26, 2026 | $540,464 |
| 75N94026D00001 NICHD: R&D: BIOLOGICAL TESTING FACILITY IDIQ: SEVERABLE | Department of Health and Human Services | — | Sep 25, 2026 | — |
| 75N91021F00001 TISSUE CROSS-REACTIVITY STUDY OF A HUMAN ANTIBODY | Department of Health and Human Services | MD | Apr 8, 2021 | $106,343 |
| 49100423F0232 EVALUATION, ASSESSMENT, AND PROGRAM MANAGEMENT SERVICES | National Science Foundation | VA | Sep 19, 2023 | $4,660,246 |
| 75N95019F00092 SRI INTERNATIONAL:1110101 [19-010371] | Department of Health and Human Services | CA | Sep 11, 2019 | $2,241,279 |
| 75N93020F00005 NONCLINICAL MICROBIOLOGICAL, SAFETY, TOXICOLOGY, AND PHARMACOKINETIC SERVICES | Department of Health and Human Services | CA | Aug 25, 2020 | $10,400,498 |
| 75N94018F00002 IGF::OT::IGF TASK ORDER HHSN27500002 - X-RAY CRYSTALLOGRAPHY CONTRACT NO. HHSN275201800007I - CHEMICAL SCREENING AND OPTIMIZATION FACILITY PERIOD OF PERFORMANCE 09/27/18 - 03/26/2021 | Department of Health and Human Services | CA | Sep 27, 2018 | $137,036 |
| HHSO100201500032C IGF::OT::IGF | Department of Health and Human Services | — | Sep 25, 2015 | — |
| 75N93019F00131 ANIMAL MODEL DEVELOPMENT AND INITIAL EFFICACY TESTING | Department of Health and Human Services | CA | Sep 24, 2019 | $9,282,916 |
| 75N93021F00002 THE PURPOSE OF THIS TASK ORDER IS THE DEVELOPMENT AND DELIVERY OF A QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) PLAN AND PARTICIPATION IN THE TASK ORDER INITIATION MEETING. | Department of Health and Human Services | CA | Apr 6, 2021 | $25,179 |
| HHSN271201600006I IGF::OT::IGF ID/IQ PARENT AWARD FOR PHARMACOLOGY AND TOXICOLOGY FOR THERAPEUTICS PROGRAM (PTTP)- SRI INTERNATIONAL | Department of Health and Human Services | — | Sep 13, 2016 | — |
| 75N91023D00009 ANALYSIS AND SYNTHESIS OF GMP AND NON-GMP BULK DRUGS AND PHARMACEUTICAL FORMULATIONS | Department of Health and Human Services | — | Apr 10, 2023 | — |
| 75N93021F00006 CONTRACT #HHSN272201800001I; SRI INTERNATIONAL; GMP MANUFACTURING OF OXFENDAZOLE CLINICAL TRIAL MATERIAL AND STABILITY STUDY; OA TASK 75N93021F00006; MIS TASK TOIA21C13PIPB-1; BASE AWARD; CAN 8470036; TOTAL $381,002.00 | Department of Health and Human Services | CA | Jul 27, 2021 | $630,604 |
| 75N93021F00002 ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING | Department of Health and Human Services | CA | Sep 20, 2021 | $11,164,074 |
| HHSN27100003 IGF::OT::IGF TASK ORDER #3, "CONTINUOUS RODENT AND NON-RODENT PHARMACOKINETIC ASSESSMENTS" | Department of Health and Human Services | CA | Sep 22, 2017 | $2,910,493 |
| 80ARC020F0015 RESEARCH AND DEVELOPMENT IN ADVANCED AIRCRAFT DESIGN - TASK 4 HYPERION | National Aeronautics and Space Administration | CA | Nov 19, 2019 | $249,942 |
| 75N93021F00007 NON-CLINICAL SERVICES FOR THE DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASES | Department of Health and Human Services | MI | Sep 8, 2021 | $1,749,885 |
| 75N94020D00003 BIOLOGICAL TESTING FACILITY IDIQ | Department of Health and Human Services | — | Aug 31, 2020 | — |
| 49100419F0086 ANALYTICAL AND TECHNICAL SUPPORT SERVICES CONTRACT FOR NCSES | National Science Foundation | VA | Aug 28, 2019 | $859,982 |
| 75N94021F00002 75N9420D00003 - BIOLOGICAL TESTING FACILITY, TASK ORDER 5: WEBSITE - SRI INTERNATIONAL - CAN 8030701 | Department of Health and Human Services | CA | Jan 7, 2021 | $195,958 |
| 75N94021F00001 CONTRACT: HHSN275201800007I - CHEMICAL SCREENING AND OPTIMIZATION FACILITY TASK ORDER: 75N94021F0000 (TASK ORDER 7)- HIGH THROUGHPUT SCREENING POP: 5/28/21 - 9/30/23 | Department of Health and Human Services | CA | May 28, 2021 | $859,180 |
| 75N94020F00001 HHSN275201500002I - BIOLOGICAL TESTING FACILITY TASK ORDER 16: CLINICAL MANUFACTURING, FORMULATION DEVELOPMENT AND STABILITY TESTING - SRI INTERNATIONAL - CAN 8030701 | Department of Health and Human Services | CA | Apr 29, 2020 | $834,408 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier SRG2J1WS9X63, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.